Delving into the Latest Updates on Xinhe Yuansheng Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

Opioid receptors x mAChRs	1

1.研究空腹单次口服马来酸曲美布汀片受试制剂（100mg，持证商：信合援生制药股份有限公司）与马来酸曲美布汀片参比制剂（100mg，持证商：田边三菱制药株式会社）后曲美布汀在中国健康受试者体内的药代动力学行为，评价空腹口服两种制剂的人体生物等效性。 2.研究餐后单次口服马来酸曲美布汀片受试制剂（100mg，持证商：信合援生制药股份有限公司）与马来酸曲美布汀片参比制剂（100mg，持证商：田边三菱制药株式会社）后曲美布汀在中国健康受试者体内的药代动力学行为，评价餐后口服两种制剂的人体生物等效性。次要目的：评价中国健康受试者空腹和餐后单次口服马来酸曲美布汀片受试制剂和参比制剂后的安全性。

[Translation]

1. To study the pharmacokinetic behavior of trimebutine maleate tablets (100 mg, licensee: Xinhe Yuansheng Pharmaceutical Co., Ltd.) and the reference formulation of trimebutine maleate tablets (100 mg, licensee: Mitsubishi Tanabe Pharma Co., Ltd.) after a single oral administration on an empty stomach in healthy Chinese subjects, and to evaluate the bioequivalence of the two formulations after oral administration on an empty stomach. 2. To study the pharmacokinetic behavior of trimebutine maleate tablets (100 mg, licensee: Xinhe Yuansheng Pharmaceutical Co., Ltd.) and the reference formulation of trimebutine maleate tablets (100 mg, licensee: Mitsubishi Tanabe Pharma Co., Ltd.) after a single oral administration on an empty stomach in healthy Chinese subjects, and to evaluate the bioequivalence of the two formulations after oral administration on a empty stomach. Secondary objective: To evaluate the safety of the test and reference formulations of trimebutine maleate tablets in healthy Chinese subjects after a single oral administration on an empty stomach and after a meal.

Start Date27 Jun 2023

Sponsor / Collaborator

Xinhe Yuansheng Pharmaceutical Co., Ltd.

100 Clinical Results associated with Xinhe Yuansheng Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Xinhe Yuansheng Pharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Xinhe Yuansheng Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Xinhe Yuansheng Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data